A prospective study to evaluate the effectiveness of dedicated breast positron emission tomography (dbPET) in patients undergoing neoadjuvant chemotherapy for breast cancer

A prospective study to evaluate the effectiveness of dedicated breast positron emission tomography (dbPET) in patients undergoing neoadjuvant chemotherapy for breast cancer - To evaluate the effectiveness of dbPET in patients undergoing neoadjuvant chemotherapy for breast cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000012517

Enrollment

Registered

2013-12-09

Start date

2013-12-09

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer

Interventions

Perform dbPET scan for patients undergoing neoadjuvant chemotherapy for breast cancer, and to analyze the correlation between the FDG uptake of the lesions and pathological diagnosis or the MRI diagno

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: The patients undergoing neoadjuvant chemotherapy for breast cancer

Exclusion criteria

Exclusion criteria: 1.Pregnant and possibly pregnant women 2.Other patients determined to be inappropriate by physician

Design outcomes

Primary

Measure	Time frame
Comparison with the pathological findings	—

Secondary

Measure	Time frame
Comparison with MRI diagnosis	—

Countries

Japan

Contacts

Public ContactSadatoshi Sugae Sadatoshi

Graduate School of Medicine, Yokohama City University Department of gastroterological surgery

sugae@yokohama-cu.ac.jp045-787-2650

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026